[Discussion] we are measuring TGA at the wrong time and calling it noise
Thinking out loud about this: we are measuring TGA at the wrong time and calling it noise.
Personal importation provisions exist, are narrow, and carry conditions. Any summary of them here should be checked against the current official wording rather than a forum post.
Subsidy criteria and authority requirements are published. For eligibility questions those documents are authoritative and this board is not.
Checked the shortage database myself instead of reading the coverage. Expected resolution date was right there and the panic thread was wrong.
Research-use-only material is not approved for human use and nothing here should be read as a recommendation to use it.
best — the order this archive was captured in
Pharmacy-level availability and national supply are different questions: a pharmacy can be out while the wholesaler is not, and the pharmacist can check in minutes.
Same. Private pricing varies here as much as anywhere and people assume it is fixed.
That figure is a private price at one pharmacy, not a national one.
pharmacy stock and national supply are different questions
PBS listing and TGA registration are two different questions
Small fix — that is the New Zealand arrangement, and the question is about Australia.
PBS listing and TGA registration are two different questions
This is the distinction that makes the rest of the board legible.
Pharmacy staff name removed; the pharmacy itself can stay in a pricing post.
The national shortage database is a primary source with expected resolution dates attached. It is public, searchable, and consistently more accurate than reporting about it.
Asked the pharmacist to check the wholesaler and had a definite answer in about four minutes.
Careful, personal importation provisions are narrow and specific and the general version circulating here is wrong.
a streamlined authority code is not the same as a general listing
Cosigning on asking the pharmacy to check the wholesaler. It converts speculation into a fact in one phone call.
Registration by the therapeutic goods regulator establishes that a product may be supplied. Subsidy listing is a separate decision about public funding, with its own criteria and its own timetable.
Did the pharmacy check with the wholesaler, or is that a shelf observation?
Australia and New Zealand have different regulators, different funding bodies and different arrangements. An answer for one is not evidence about the other.
Compounded supply arrangements have changed materially in recent years. Advice predating that change describes a situation that no longer applies.
Kept the script and the receipt for a private health claim and both were requested.
ask the pharmacy to check the wholesaler rather than guessing
Where to look instead of asking, which will nearly always be faster.
The national shortage database is public, searchable and carries expected resolution dates. The subsidy criteria for each indication are published. Your pharmacist can check wholesaler availability in a few minutes, which is a different question from what is on the shelf.
Between those three, most questions on this board are answerable in half an hour with primary sources. The board is genuinely useful for experience, pricing comparison and the parts that are not written down anywhere — it is a poor substitute for a document that exists.
Are you quoting advice from before the compounded arrangements changed?
compounded supply arrangements changed and the threads have not caught up
the Medsafe position in New Zealand is its own thing entirely
- 1pharmacy stock and national supply are different questions6 comments in this branch · started by u/ismael_pires